Ami Dagan

Quai mitigates care variability by standardizing physician’s decision making with an AI-based platform for personalized clinical pathways. Clinical pathways are decision trees, defined based on medical research, for patients with a certain condition. Quai captures these pathways, personalizes them using its proprietary AI-engine, and presents them to the physician at the point of care. Physicians trust our platform because it builds on evidence-based pathways. Physicians love our platform because we make those pathways accessible, translating them into a live and interactive click-through tool that is embedded within their workflow. Physicians feel empowered by our platform because our AI-engine tailors the pathway to the specific patient, while allowing physicians full flexibility to choose whatever path they see fit.

Welcome to the Era of Automated Architectural Capabilities! qbiq is the first Architectural AI platforms that allows brokers, landlords, architects, general contractors, and tenants to easily envision the full potential of any space in minutes, while considering basic or complex requirements. Customers such as Brookfield Properties, JLL, Skanska and IWG are able to easily create a wide range of architectural outputs for any space in minutes. These outputs include architectural programs, programmatic or conceptual layouts, high-resolution rendered tours and images, quantity takeoffs CAD/Revit models and more.

FeelBetter’s AI-powered platform for polypharmacy patient management mitigates the consequences of suboptimal medication management. Our platform identifies patients at high risk of polypharmacy-related deterioration and hospitalization, recommends changes to medication regimens and other needed clinical interventions, and monitors post-intervention progress at the individual, population, and operational levels. To learn more, visit feelbetter.healthcare.

Beaconcure supports biopharmaceutical companies and CROs with Verify, a secure online workspace for AI-enabled clinical study analysis validation. Designed in partnership with trusted large pharmaceutical companies and used in an increasing number of approved products, Verify streamlines validation workflows, reduces error rates, and increases efficiency compared to traditional processes. Beaconcure is revolutionizing the way new drugs and vaccines are approved for market by replacing manual processes with deep tech. Accurate analysis of clinical research data is critical to helping millions of people receive safe and effective medical treatments faster, and Verify provides assurance that these analyses are of the highest integrity. In June 2023, Beaconcure raised $14 million in Series B financing. By working at Beaconcure, you can reshape and impact the speed at which new medications aid patients, many of whom may be your family or friends. You will also help drive the translation of meaningful ideas into beneficial products with the support of an inclusive and diverse group of highly talented professionals. View open positions here: https://www.comeet.com/jobs/beaconcure/E8.004 #machinelearning #AI #statisticalanalysis #regulatorysubmission #clinicaltrial #dataintegrity

REALEXTATE is an innovative fast growing FinTech company that developed a crowdfunding & exchange technology enabling investors to invest in properties world wide. With solving the 3 major issues for real estate investors (high capital, liquidity, ongoing issues), our technology is the best for "Invest in real estate at a click of a button“. At REALEXTATE, we believe in the importance of financial portfolio diversification with smart investment moves. Our real estate exchange platform is the first ever exchange to work 24\​7 anywhere, anytime. Properties are open for investments starting from $1,000 Providing full transparency with videos, pictures and reports. REALEXTATE has developed a unique legal structure that enables clients to invest in properties by pieces. Each asset is bought separately and uploaded into REALEXTATE’s platform, where each investor can choose which asset to buy and how much % he would like to invest in every asset. The platform is built using an exchange technology for trading option, so once you invest you can also put some or all of your investment for sale.

Random Forest is a boutique early-stage fund. We focus on market disruptive ventures, based on cutting-edge Machine Learning and Artificial Intelligence technologies. The partners of Random Forest pioneered as executives of companies where machine learning was a key factor to their success. We invest in ventures with superior technologies at their very early stage of formation, led by extraordinary entrepreneurs who are passionate to disrupt the market they are taking part in. We support the entrepreneurs with Machine Learning development services to accelerate their development, allowing their venture to enjoy fast growth.

Quai mitigates care variability by standardizing physician’s decision making with an AI-based platform for personalized clinical pathways. Clinical pathways are decision trees, defined based on medical research, for patients with a certain condition. Quai captures these pathways, personalizes them using its proprietary AI-engine, and presents them to the physician at the point of care. Physicians trust our platform because it builds on evidence-based pathways. Physicians love our platform because we make those pathways accessible, translating them into a live and interactive click-through tool that is embedded within their workflow. Physicians feel empowered by our platform because our AI-engine tailors the pathway to the specific patient, while allowing physicians full flexibility to choose whatever path they see fit.

Welcome to the Era of Automated Architectural Capabilities! qbiq is the first Architectural AI platforms that allows brokers, landlords, architects, general contractors, and tenants to easily envision the full potential of any space in minutes, while considering basic or complex requirements. Customers such as Brookfield Properties, JLL, Skanska and IWG are able to easily create a wide range of architectural outputs for any space in minutes. These outputs include architectural programs, programmatic or conceptual layouts, high-resolution rendered tours and images, quantity takeoffs CAD/Revit models and more.

FeelBetter’s AI-powered platform for polypharmacy patient management mitigates the consequences of suboptimal medication management. Our platform identifies patients at high risk of polypharmacy-related deterioration and hospitalization, recommends changes to medication regimens and other needed clinical interventions, and monitors post-intervention progress at the individual, population, and operational levels. To learn more, visit feelbetter.healthcare.

Beaconcure supports biopharmaceutical companies and CROs with Verify, a secure online workspace for AI-enabled clinical study analysis validation. Designed in partnership with trusted large pharmaceutical companies and used in an increasing number of approved products, Verify streamlines validation workflows, reduces error rates, and increases efficiency compared to traditional processes. Beaconcure is revolutionizing the way new drugs and vaccines are approved for market by replacing manual processes with deep tech. Accurate analysis of clinical research data is critical to helping millions of people receive safe and effective medical treatments faster, and Verify provides assurance that these analyses are of the highest integrity. In June 2023, Beaconcure raised $14 million in Series B financing. By working at Beaconcure, you can reshape and impact the speed at which new medications aid patients, many of whom may be your family or friends. You will also help drive the translation of meaningful ideas into beneficial products with the support of an inclusive and diverse group of highly talented professionals. View open positions here: https://www.comeet.com/jobs/beaconcure/E8.004 #machinelearning #AI #statisticalanalysis #regulatorysubmission #clinicaltrial #dataintegrity